Intuitive Surgical Maintains 'Strong Buy' Rating Despite 13.5% Stock Decline

Intuitive Surgical (ISRG) has seen its stock price decline by 13.5% over the past three months, reflecting recent market volatility. Despite this pullback, the stock maintains a Zacks Rank #1 (Strong Buy), signaling robust underlying fundamentals. Analysts project that global da Vinci procedure growth will reach between 13% and 15% by 2026. While the company faces headwinds from margin pressures and rising competition, its leadership in the robotic surgery market remains undisputed. The ongoing adoption of the da Vinci 5 system is expected to further solidify its competitive advantage. Investors are closely watching these growth projections as the recent price dip may offer a strategic entry point for long-term gains.